Suzhou Novoprotein Financials
| 688137 Stock | 36.25 0.84 2.37% |
Suzhou |
Understanding current and past Suzhou Novoprotein Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Suzhou Novoprotein's financial statements are interrelated, with each one affecting the others. For example, an increase in Suzhou Novoprotein's assets may result in an increase in income on the income statement.
Please note, the presentation of Suzhou Novoprotein's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Suzhou Novoprotein's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Suzhou Novoprotein's management manipulating its earnings.
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| Business Address | No228, Yunchuang Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.novoprotein.com.cn |
| Phone | 86 512 6391 9116 |
You should never invest in Suzhou Novoprotein without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Suzhou Stock, because this is throwing your money away. Analyzing the key information contained in Suzhou Novoprotein's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Suzhou Novoprotein Key Financial Ratios
Suzhou Novoprotein's financial ratios allow both analysts and investors to convert raw data from Suzhou Novoprotein's financial statements into concise, actionable information that can be used to evaluate the performance of Suzhou Novoprotein over time and compare it to other companies across industries.| Return On Equity | -0.0099 | |||
| Return On Asset | -0.0228 | |||
| Number Of Employees | 579 | |||
| Beta | 2.14 | |||
| Last Dividend Paid | 0.5 |
Suzhou Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Suzhou Novoprotein's current stock value. Our valuation model uses many indicators to compare Suzhou Novoprotein value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Suzhou Novoprotein competition to find correlations between indicators driving Suzhou Novoprotein's intrinsic value. More Info.Suzhou Novoprotein Scientific is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Suzhou Novoprotein by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Suzhou Novoprotein's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Suzhou Novoprotein Systematic Risk
Suzhou Novoprotein's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Suzhou Novoprotein volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Suzhou Novoprotein correlated with the market. If Beta is less than 0 Suzhou Novoprotein generally moves in the opposite direction as compared to the market. If Suzhou Novoprotein Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Suzhou Novoprotein is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Suzhou Novoprotein is generally in the same direction as the market. If Beta > 1 Suzhou Novoprotein moves generally in the same direction as, but more than the movement of the benchmark.
Suzhou Novoprotein December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Suzhou Novoprotein help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Suzhou Novoprotein Scientific. We use our internally-developed statistical techniques to arrive at the intrinsic value of Suzhou Novoprotein Scientific based on widely used predictive technical indicators. In general, we focus on analyzing Suzhou Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Suzhou Novoprotein's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.18 | |||
| Information Ratio | 0.0689 | |||
| Maximum Drawdown | 22.24 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 5.19 |
Complementary Tools for Suzhou Stock analysis
When running Suzhou Novoprotein's price analysis, check to measure Suzhou Novoprotein's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suzhou Novoprotein is operating at the current time. Most of Suzhou Novoprotein's value examination focuses on studying past and present price action to predict the probability of Suzhou Novoprotein's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Suzhou Novoprotein's price. Additionally, you may evaluate how the addition of Suzhou Novoprotein to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |